Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
C18 NEGATIVE ION MODE | FFA(20:0) | 1180555.029 | Peak area normalized | male | diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1245697.33 | Peak area normalized | female | diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1248975.196 | Peak area normalized | male | pre-diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1254597.343 | Peak area normalized | female | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1320330.373 | Peak area normalized | female | diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1333167.856 | Peak area normalized | female | normoglycemic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1372885.959 | Peak area normalized | female | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1485883.951 | Peak area normalized | female | diabetic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1510822.196 | Peak area normalized | female | normoglycemic | Neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1652304.306 | Peak area normalized | female | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1776784.045 | Peak area normalized | male | pre-diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 1905895.824 | Peak area normalized | male | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 2217979.939 | Peak area normalized | female | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | FFA(20:0) | 2937285.779 | Peak area normalized | female | diabetic | Neuropathy |